Sarah Frazier Klein

Sarah Frazier Klein is an experienced marketing professional specializing in healthcare and pharmaceuticals. Currently serving as Senior Director and Lead of Hemoglobinopathy Brands at bluebird bio since August 2019, Klein has held several significant roles there, including Global Marketing Director for Sickle Cell Disease. Prior to this, Klein worked at Alkermes from June 2017 to August 2019, focusing on marketing for schizophrenia and major depressive disorder. Klein's earlier experience includes positions at United Therapeutics Corporation, where a Marketing Achievement Award was received, and TransEnterix, Inc., where various marketing and sales roles were undertaken. Klein began their career as an Account Executive at Sinclair & Co. after graduating from the University of North Carolina at Chapel Hill in 2009.